TABLE 1.
Effect of CW on the FA content of the liver of model rats (x‾ ± s, n = 6, μg/mL).
Groups | NC | M | CW-H | IBP |
---|---|---|---|---|
C14:0 | 0.0098 ± 0.01 | 0.0746 ± 0.02a | 0.0000 ± 0.00b | 0.0386 ± 0.07 |
C16:1 | 0.2419 ± 0.08 | 0.4303 ± 0.05c | 0.0499 ± 0.03d | 0.2656 ± 0.15d |
C17:0 | 0.0220 ± 0.01 | 0.0445 ± 0.01e | 0.0249 ± 0.00d | 0.0275 ± 0.01d |
C18:0 | 3.2973 ± 0.33 | 6.0820 ± 0.54a | 4.8775 ± 0.23d | 3.9935 ± 0.59d |
C18:1n9c | 1.4502 ± 0.44 | 5.3087 ± 0.42a | 1.2222 ± 0.17d | 2.6261 ± 2.64b |
C18:2n6c | 2.1782 ± 0.42 | 11.2176 ± 1.60a | 2.1207 ± 0.38d | 3.3405 ± 2.24d |
C18:3n6 | 0.0052 ± 0.01 | 0.1567 ± 0.03a | 0.0051 ± 0.00d | 0.0080 ± 0.01d |
C18:3n3 | 0.0193 ± 0.01 | 0.2396 ± 0.05a | 0.0049 ± 0.00d | 0.0304 ± 0.02d |
C20:0 | 0.0033 ± 0.00 | 0.0040 ± 0.00 | 0.0022 ± 0.00 | 0.0071 ± 0.01 |
C20:1n9 | 0.0192 ± 0.01 | 0.0169 ± 0.00 | 0.0141 ± 0.00 | 0.0286 ± 0.03 |
C20:2 | 0.0535 ± 0.02 | 0.0634 ± 0.01 | 0.0397 ± 0.01f | 0.0593 ± 0.02 |
C20:3n6 | 0.0765 ± 0.03 | 0.0634 ± 0.01 | 0.0619 ± 0.03 | 0.0850 ± 0.03 |
C20:4n6 | 2.7060 ± 0.23 | 5.5530 ± 0.64a | 4.0504 ± 0.31d | 3.1121 ± 0.11d |
C20:5n3 | 0.0325 ± 0.02 | 0.1568 ± 0.04a | 0.0096 ± 0.01d | 0.0314 ± 0.02d |
C24:1n9 | 0.1617 ± 0.03 | 0.2909 ± 0.06a | 0.3164 ± 0.05 | 0.2011 ± 0.05b |
C22:6n3 | 0.7114 ± 0.11 | 1.2548 ± 0.27a | 1.3608 ± 0.20 | 0.8718 ± 0.18b |
NC, normal control group; M, model group, CW-H, CW, high-dose group; IBP, ibuprofen positive control group.
Compared with the NC, group. a p < 0.001; compared with the M group. b p < 0.01. c p < 0.01. d p < 0.001. e p < 0.05. f p < 0.05.